Glucagon, secreted by pancreatic α-cells, plays a crucial role in glucose metabolism through its counter-regulatory effects ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.

New fleet of weight loss drugs are more effective than the current popular obesity medications at trial - One in eight ...

GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

Peptides have emerged as critical tools in the investigation of physiological homeostasis, specifically in how biological systems manage energy substrates and recover from physical trauma. By ...

If you’ve seen or read the news in the past couple of years, you’ve probably heard about the “miracle” weight loss drugs like ...

Type 2 diabetes medication Glucagon-like Peptide-1, also known as GLP-1, has grown into a popular weight loss treatment in the United States — however, some doctors are concerned with the ...

Here’s what the science says.

GLP-1 RA use is associated with improved survival and lower hospitalization rates in patients with type 2 diabetes receiving cancer therapy.

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...